• 日本語

Outline

Due to recent remarkable advances in medical technology, effective new drugs and treatment methods have emerged. Against such background of medical sophistication, technical innovations in diagnosis are now required as well. However, as the response to basic testing conducted during the diagnosis is relatively limited, it is not easy to incorporate entirely new testing methods different from conventional ones.

On the other hand, current diagnosis focuses on minimizing the pain of the subject through "non-invasive, minimally-invasive" tests, and "quick" testing in order to reduce binding time or avoid complications. This is now a global trend.

Thus, among the diverse needs that are surfacing in the testing business, our company has adopted "on-site testing" based on original technology as its slogan and has committed to research and development. The platform standing at the core of our technology is an innovative high-dimensional information acquisition method designed to achieve simultaneously the following three objectives: "minimum amount", "short time", "and many types at the same time".

Our company's mission is to use this new technology for finding solutions to yet unsolved medical problems, and for contributing to the medical care of the near future.

Key words: POCT, infection, genetic analysis, high-speed PCR, screening

 

Research and Development Project

Development of a POCT-oriented rapid screening device

For more details about this page, please contact:

Metaboscreen Co., Ltd.

Address Nagata bldg. #301, Chuo 1-31-6, Nishi-ku, Yokohama City, Kanagawa Pref. 220-0051 Japan
TEL/FAX 045-620-9903
E-mail